BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 29085371)

  • 41. Loss of Src homology region 2 domain-containing protein tyrosine phosphatase-1 increases CD8+ T cell-APC conjugate formation and is associated with enhanced in vivo CTL function.
    Sathish JG; Dolton G; Leroy FG; Matthews RJ
    J Immunol; 2007 Jan; 178(1):330-7. PubMed ID: 17182570
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ligand binding to inhibitory killer cell Ig-like receptors induce colocalization with Src homology domain 2-containing protein tyrosine phosphatase 1 and interruption of ongoing activation signals.
    Vyas YM; Maniar H; Lyddane CE; Sadelain M; Dupont B
    J Immunol; 2004 Aug; 173(3):1571-8. PubMed ID: 15265884
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Protein Tyrosine Phosphatase SHP-2 Is Involved in the Interleukin-21-Induced Activation of Extracellular Signal-Regulated Kinase 1/2.
    Jin L; Nara H; Rahman M; Takeda Y; Araki A; Asao H
    Tohoku J Exp Med; 2018 Mar; 244(3):187-193. PubMed ID: 29503347
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Spontaneous chondroma formation in CD2-Cre-driven Erk-deficient mice.
    Shiokawa M; Lu X; Miyake Y; Ishikawa E; Pagès G; Pouysségur J; Ogata M; Yamasaki S
    Int Immunol; 2017 Dec; 29(10):479-485. PubMed ID: 29106539
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The tyrosine phosphatase SHP-1 influences thymocyte selection by setting TCR signaling thresholds.
    Carter JD; Neel BG; Lorenz U
    Int Immunol; 1999 Dec; 11(12):1999-2014. PubMed ID: 10590266
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mechanisms of SHP-1 P2 promoter regulation in hematopoietic cells and its silencing in HTLV-1-transformed T cells.
    Nakase K; Cheng J; Zhu Q; Marasco WA
    J Leukoc Biol; 2009 Jan; 85(1):165-74. PubMed ID: 18948549
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Negative autoregulation of Src homology region 2-domain-containing phosphatase-1 in rat basophilic leukemia-2H3 cells.
    Ozawa T; Nakata K; Mizuno K; Yakura H
    Int Immunol; 2007 Sep; 19(9):1049-61. PubMed ID: 17675340
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The tyrosine phosphatase SHP-2 is required for mediating phosphatidylinositol 3-kinase/Akt activation by growth factors.
    Wu CJ; O'Rourke DM; Feng GS; Johnson GR; Wang Q; Greene MI
    Oncogene; 2001 Sep; 20(42):6018-25. PubMed ID: 11593409
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Negative regulation of myeloid cell proliferation and function by the SH2 domain-containing tyrosine phosphatase-1.
    Dong Q; Siminovitch KA; Fialkow L; Fukushima T; Downey GP
    J Immunol; 1999 Mar; 162(6):3220-30. PubMed ID: 10092773
    [TBL] [Abstract][Full Text] [Related]  

  • 50. SHP-2, SH2-containing protein tyrosine phosphatase-2.
    Stein-Gerlach M; Wallasch C; Ullrich A
    Int J Biochem Cell Biol; 1998 May; 30(5):559-66. PubMed ID: 9693956
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Src homology 2 domain tyrosine phosphatases SHP-1 and SHP-2: diversified control of cell growth, inflammation, and injury.
    Chong ZZ; Maiese K
    Histol Histopathol; 2007 Nov; 22(11):1251-67. PubMed ID: 17647198
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The alphaVbeta3 integrin regulates insulin-like growth factor I (IGF-I) receptor phosphorylation by altering the rate of recruitment of the Src-homology 2-containing phosphotyrosine phosphatase-2 to the activated IGF-I receptor.
    Maile LA; Clemmons DR
    Endocrinology; 2002 Nov; 143(11):4259-64. PubMed ID: 12399420
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The tyrosine phosphatase SHP-1 inhibits proliferation of activated hepatic stellate cells by impairing PDGF receptor signaling.
    Tibaldi E; Zonta F; Bordin L; Magrin E; Gringeri E; Cillo U; Idotta G; Pagano MA; Brunati AM
    Biochim Biophys Acta; 2014 Feb; 1843(2):288-98. PubMed ID: 24140598
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Thymic commitment of regulatory T cells is a pathway of TCR-dependent selection that isolates repertoires undergoing positive or negative selection.
    Coutinho A; Caramalho I; Seixas E; Demengeot J
    Curr Top Microbiol Immunol; 2005; 293():43-71. PubMed ID: 15981475
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The phosphatase SRC homology region 2 domain-containing phosphatase-1 is an intrinsic central regulator of dendritic cell function.
    Ramachandran IR; Song W; Lapteva N; Seethammagari M; Slawin KM; Spencer DM; Levitt JM
    J Immunol; 2011 Apr; 186(7):3934-45. PubMed ID: 21357539
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The phosphotyrosine phosphatase SHP-2 participates in a multimeric signaling complex and regulates T cell receptor (TCR) coupling to the Ras/mitogen-activated protein kinase (MAPK) pathway in Jurkat T cells.
    Frearson JA; Alexander DR
    J Exp Med; 1998 May; 187(9):1417-26. PubMed ID: 9565634
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression of dominant-negative src-homology domain 2-containing protein tyrosine phosphatase-1 results in increased Syk tyrosine kinase activity and B cell activation.
    Dustin LB; Plas DR; Wong J; Hu YT; Soto C; Chan AC; Thomas ML
    J Immunol; 1999 Mar; 162(5):2717-24. PubMed ID: 10072516
    [TBL] [Abstract][Full Text] [Related]  

  • 58. SHP-1 regulates STAT6 phosphorylation and IL-4-mediated function in a cell type-specific manner.
    Huang Z; Coleman JM; Su Y; Mann M; Ryan J; Shultz LD; Huang H
    Cytokine; 2005 Feb; 29(3):118-24. PubMed ID: 15613279
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Receptor activator of NF-kappa B ligand stimulates recruitment of SHP-1 to the complex containing TNFR-associated factor 6 that regulates osteoclastogenesis.
    Zhang Z; Jimi E; Bothwell AL
    J Immunol; 2003 Oct; 171(7):3620-6. PubMed ID: 14500659
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CD45 regulates tyrosine phosphorylation of CD22 and its association with the protein tyrosine phosphatase SHP-1.
    Greer SF; Justement LB
    J Immunol; 1999 May; 162(9):5278-86. PubMed ID: 10228003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.